BTA 0.00% 57.0¢ biota holdings limited

strategic review out , page-13

  1. 13,916 Posts.
    lightbulb Created with Sketch. 124
    Mate, these guys never cease to amaze me with their ability to surprise on the upside when it comes to poor communications.

    1. We have a Gyrase Gram Positive candidate (with requisitive posters on the website). They now say we are pursuing Gyrase Gram Negative? Does that mean this program is now not as advanced as it was when we put the Gram Positive up for license?

    2. NIH funded C Diff? Where is it?

    3. Nicvax? Gone?

    4. HRV? WTF is the situation? What is "several quarters"? Why use the word "independently"? Why not just say we are deciding whether to continue it full stop?

    5. Explain RSV. How much time have we lost? What's the problem and how does this impact our backups?

    6. Which Gram Positive programs are we "continuing to pursue out licensing"? C Diff? Gyrase?

    7. If we are reducing programs and workforce (by 30%), WTF aren't we reducing board numbers?


 
watchlist Created with Sketch. Add BTA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.